GO
Loading...

Allergan Grows on Product Strategy

Wednesday, 3 Aug 2011 | 6:55 PM ET

Mad Money host Jim Cramer explains why Allergan isn't about to fall off a patent cliff like so many other big pharma companies. David Pyott, Allergan chairman, president & CEO weighs in on the company's earnings.